🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the producers of acetaminophen, alleging the corporations hid potential risks that the medication created to children's cognitive development.

This legal action comes a month after Former President Trump publicized an unproven link between taking acetaminophen - also known as paracetamol - throughout gestation and autism spectrum disorder in children.

The attorney general is filing suit against Johnson & Johnson, which once produced the medication, the only pain reliever suggested for expectant mothers, and Kenvue, which currently produces it.

In a official comment, he stated they "misled consumers by making money from suffering and promoting medication without regard for the potential hazards."

The company asserts there is no credible evidence tying Tylenol to autism spectrum disorder.

"These manufacturers lied for decades, deliberately risking numerous people to increase profits," the attorney general, from the Republican party, said.

Kenvue said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the security of acetaminophen and the potential impact that could have on the welfare of American women and children."

On its online platform, Kenvue also stated it had "consistently assessed the pertinent research and there is no credible data that demonstrates a verified association between taking paracetamol and autism spectrum disorder."

Associations representing doctors and health professionals share this view.

The American College of Obstetricians and Gynecologists has said acetaminophen - the key substance in Tylenol - is among limited choices for expectant mothers to address pain and fever, which can pose major wellness concerns if not addressed.

"In more than two decades of studies on the consumption of acetaminophen in gestation, no reliable research has definitively established that the consumption of acetaminophen in any period of pregnancy causes brain development issues in offspring," the association stated.

This legal action mentions current declarations from the previous government in asserting the medication is reportedly hazardous.

Last month, Trump generated worry from medical authorities when he advised women during pregnancy to "resist strongly" not to consume acetaminophen when ill.

The FDA then released a statement that doctors should consider limiting the usage of Tylenol, while also declaring that "a direct connection" between the drug and autism spectrum disorder in minors has not been proven.

The Health Department head Robert F Kennedy Jr, who supervises the Food and Drug Administration, had pledged in April to undertake "a massive testing and research effort" that would identify the cause of autism spectrum disorder in a matter of months.

But experts warned that identifying a sole reason of autism - considered by experts to be the consequence of a complex mix of genetic and environmental factors - would prove challenging.

Autism is a type of enduring cognitive variation and condition that influences how people perceive and relate to the surroundings, and is recognized using physician assessments.

In his court filing, the attorney general - aligned with the former president who is running for US Senate - claims Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

This legal action aims to force the firms "remove any commercial messaging" that states Tylenol is secure for women during pregnancy.

The Texas lawsuit echoes the concerns of a group of mothers and fathers of children with autism spectrum disorder and ADHD who took legal action against the producers of Tylenol in 2022.

The court rejected the lawsuit, saying studies from the family's specialists was inconclusive.